I don't really think it matters what the platform is used for as long as it is used. Traditional Chinese medicine to my knowledge is just natural things as opposed to pharmaceutical medication. They still need to check their glucose levels in a blood glucose meter and if they use ALRT it will upload the readings to the TCM doctor they are seeing.
I think the more users the better, whether the medication/doctor is natural/pharma isn't relevant in my opinion.
In regard to the move, I know the company announced plans to redomicile to Canada but that was never executed from looking at the filings. I would assume that is because Singapore is more relevant to be a global leader as the PR talks about and also because of all the initiatives they have and are targeting in South East Asia...
Bottom line in my opinion, where the company is domiciled has no impact I can see positive or negative unless it has something to do with co-listing on other markets which would create more demand and be a good thing. Other then that I can't think of any reasons it would it matter to shareholders?
Market Data 
Markets 
AI
